References
- Dai X-L, Yao J, Wu C, et al. Solubility and permeability improvement of allopurinol by cocrystallization. Cryst Growth Des. 2020;20(8):5160–5168.
- Cairo MS, Thompson S, Tangirala K, et al. A clinical and economic comparison of rasburicase and allopurinol in the treatment of patients with clinical or laboratory tumor lysis syndrome. Clin Lymphoma Myeloma Leuk. 2017;17(3):173–178.
- Sparrow MP, Hande SA, Friedman S, et al. Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine. Clin Gastroenterol Hepatol. 2007;5(2):209–214.
- Cicero AFG, Cosentino ER, Kuwabara M, et al. Effects of allopurinol and febuxostat on cardiovascular mortality in elderly heart failure patients. Intern Emerg Med. 2019;14(6):949–956.
- Kim SC, Newcomb C, Margolis D, et al. Severe cutaneous reactions requiring hospitalization in allopurinol initiators: a population-based cohort study. Arthritis Care Res. 2013;65(4):578–584.
- Stamp LK, Barclay ML. How to prevent allopurinol hypersensitivity reactions? Rheumatology. 2018;57(Suppl. 1):i35–i41.
- Tiwari R, Tiwari G, Singh R. Allopurinol loaded transferosomes for the alleviation of symptomatic after-effects of gout: an account of pharmaceutical implications. Curr Drug Ther. 2020;15(4):404–419.
- Kandav G, Bhatt D, Jindal DK. Formulation and evaluation of allopurinol loaded chitosan nanoparticles. Int J Appl Pharm. 2019;11(3):49–52.
- Shingade GM, Quazi A, Sabale PM, et al. Review on: recent trend on transdermal drug delivery system. J Drug Deliv Ther. 2012;2(1):66–75.
- Chen J, Gao Y. Strategies for meloxicam delivery to and across the skin: a review. Drug Deliv. 2016;23(8):3146–3156.
- Parhi R, Mandru A. Enhancement of skin permeability with thermal ablation techniques: concept to commercial products. Drug Deliv Transl Res. 2021;11(3):817–825.
- Ramadon D, McCrudden MT, Courtenay AJ, et al. Enhancement strategies for transdermal drug delivery systems: current trends and applications. Drug Deliv Transl Res. 2021;1–34.
- Chen J, Huang W, Huang Z, et al. Fabrication of tip-dissolving microneedles for transdermal drug delivery of meloxicam. AAPS PharmSciTech. 2018;19(3):1141–1151.
- Ita K. Dissolving microneedles for transdermal drug delivery: advances and challenges. Biomed Pharmacother. 2017;93:1116–1127.
- Chen J, Wang M, Ye Y, et al. Fabrication of sponge-forming microneedle patch for rapidly sampling interstitial fluid for analysis. Biomed Microdev. 2019;21(3):63.
- Aung NN, Ngawhirunpat T, Rojanarata T, et al. Fabrication, characterization and comparison of α-arbutin loaded dissolving and hydrogel forming microneedles. Int J Pharm. 2020;586:119508.
- Samy E, Hassan M, Tous S, et al. Improvement of availability of allopurinol from pharmaceutical dosage forms I – suppositories. Eur J Pharm Biopharm. 2000;49(2):119–127.
- Bala I, Bhardwaj V, Hariharan S, et al. Sustained release nanoparticulate formulation containing antioxidant-ellagic acid as potential prophylaxis system for oral administration. J Drug Target. 2006;14(1):27–34.
- Chen J, Li Q, Ye Y, et al. Inhibition of xanthine oxidase by theaflavin: possible mechanism for anti-hyperuricaemia effect in mice. Process Biochem. 2020;97:11–18.
- Carroll JJ, Coburn H, Douglass R, et al. A simplified alkaline phosphotungstate assay for uric acid in serum. Clin Chem. 1971;17(3):158–160.
- Chen J, Qiu Y, Zhang S, et al. Dissolving microneedle-based intradermal delivery of interferon-α-2b. Drug Dev Ind Pharm. 2016;42(6):890–896.
- Chen Y, Chen BZ, Wang QL, et al. Fabrication of coated polymer microneedles for transdermal drug delivery. J Control Release. 2017;265:14–21.
- Kale M, Kipping T, Banga AK. Modulated delivery of donepezil using a combination of skin microporation and iontophoresis. Int J Pharm. 2020;589:119853.
- Davis SP, Landis BJ, Adams ZH, et al. Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force. J Biomech. 2004;37(8):1155–1163.
- Larrañeta E, Stewart S, Fallows SJ, et al. A facile system to evaluate in vitro drug release from dissolving microneedle arrays. Int J Pharm. 2016;497(1–2):62–69.
- Song JE, Jun S-H, Park S-G, et al. A semi-dissolving microneedle patch incorporating TEMPO-oxidized bacterial cellulose nanofibers for enhanced transdermal delivery. Polymers. 2020;12(9):1873.
- Roberts MS, Cross S, Anissimov Y. Factors affecting the formation of a skin reservoir for topically applied solutes. Skin Pharmacol Physiol. 2004;17(1):3–16.
- Ranamukhaarachchi SA, Stoeber B. Determining the factors affecting dynamic insertion of microneedles into skin. Biomed Microdev. 2019;21(4):100.
- Zhou C-P, Liu Y-L, Wang H-L, et al. Transdermal delivery of insulin using microneedle rollers in vivo. Int J Pharm. 2010;392(1–2):127–133.
- Chang H, Zheng M, Yu X, et al. A swellable microneedle patch to rapidly extract skin interstitial fluid for timely metabolic analysis. Adv Mater. 2017;29(37):1702243.